African Pharmaceutical Review
.
African Pharmaceutical Review
.
Trending
SAHPRA signs MoU with Rwanda Food and Drug Authority
Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis
WHO prequalifies diagnostic test to minimize hemolysis from antimalarial drugs
Write For Us
|
Advertise with us
Sign In
Subscribe
Home
News
Articles
Interviews
Videos
Webinars
Publications
Whitepapers/Application Notes
Events
Podcasts
Featured Companies
QA/QC
R&D
Supply Chain
Digitalization
Analytical Techniques
Manufacturing
Regulatory affairs
Biopharma
Drug delivery
Formulation
Subscribe
Sign In
News
Articles
Interviews
Videos
Webinars
Publications
Whitepapers/Application Notes
Events
Podcasts
R&D
View All
Injectable drug shows 99.9% efficacy in HIV prevention
by
APR Team
28 Nov, 2024
1 Mins Read
AstraZeneca’s first in class therapy shows efficacy in metastatic prostate cancer
by
APR Team
26 Nov, 2024
1 Mins Read
FDA accepts for review GSK’s new multiple myeloma therapy
by
APR Team
26 Nov, 2024
1 Mins Read
Drug shows reduced risk of progression to type 2 diabetes in pre-diabetics
by
APR Team
15 Nov, 2024
1 Mins Read
Selumetinib shows efficacy in adult patients with neurofibromatosis
by
APR Team
13 Nov, 2024
1 Mins Read
AbbVie’s emraclidine fails to demonstrate efficacy in management of schizophrenia
by
APR Team
12 Nov, 2024
1 Mins Read
Anti-asthmatic therapy shows efficacy in treatment of chronic rhinosinusitis with nasal polyps
by
APR Team
09 Nov, 2024
1 Mins Read
Regeneron’s dupilumab has achieved approval in Europe as the first treatment approved for children with eosinophilic esophagitis
by
APR Team
06 Nov, 2024
1 Mins Read
GSK acquires new investigational therapy targeted for lupus treatment
by
APR Team
30 Oct, 2024
1 Mins Read
AstraZeneca’s brand of benralizumab gains approval in Europe
by
APR Team
29 Oct, 2024
1 Mins Read
Oral semaglutide shows reduction in risk of major adverse cardiovascular events in diabetic patients
by
APR Team
22 Oct, 2024
1 Mins Read
First once-daily subcutaneous prophylactic treatment for hemophilia recommended for European approval
by
APR Team
20 Oct, 2024
1 Mins Read
Innovative subcutaneous combination therapy receives approval for Parkinson's disease
by
APR Team
18 Oct, 2024
1 Mins Read
GSK’s first-in-class antibiotic with new mechanism of action approved for priority review
by
APR Team
16 Oct, 2024
1 Mins Read
AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule
by
APR Team
07 Oct, 2024
1 Mins Read
FDA approves drug with new pharmacological approach to schizophrenia treatment
by
APR Team
27 Sep, 2024
1 Mins Read
AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment
by
APR Team
23 Sep, 2024
1 Mins Read
Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.
by
APR Team
20 Sep, 2024
1 Mins Read
Roche’s Xofluza reduces transmission of flu viruses, global trial shows
by
APR Team
19 Sep, 2024
1 Mins Read
Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis
by
APR Team
18 Sep, 2024
2 Mins Read
Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.
by
APR Team
17 Sep, 2024
2 Mins Read
Research shows 2-drug HIV regimen with comparable efficacy to 3-drug regimen
by
Bevin Likuyani
25 Jul, 2024
1 Mins Read
Disrupting and accelerating drug discovery for faster and more accurate lead identification
by
Bevin Likuyani
23 Jul, 2024
0 Mins Read
Get Our Latest News & Update
Submit Now
Follow Us: